BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32900572)

  • 1. Does dysfunctional autophagy contribute to immune privilege collapse and alopecia areata pathogenesis?
    Hardman JA; Nicu C; Tai C; Harries M; Mironov A; Purba TS; Paus R
    J Dermatol Sci; 2020 Oct; 100(1):75-78. PubMed ID: 32900572
    [No Abstract]   [Full Text] [Related]  

  • 2. Hair Follicle Immune Privilege Revisited: The Key to Alopecia Areata Management.
    Paus R; Bulfone-Paus S; Bertolini M
    J Investig Dermatol Symp Proc; 2018 Jan; 19(1):S12-S17. PubMed ID: 29273098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collapse and Restoration of Hair Follicle Immune Privilege Ex Vivo: A Model for Alopecia Areata.
    Fehrholz M; Bertolini M
    Methods Mol Biol; 2020; 2154():133-141. PubMed ID: 32314213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collapse of immune privilege in alopecia areata: coincidental or substantial?
    Gilhar A
    J Invest Dermatol; 2010 Nov; 130(11):2535-7. PubMed ID: 20944635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alopecia areata: a review of disease pathogenesis.
    Rajabi F; Drake LA; Senna MM; Rezaei N
    Br J Dermatol; 2018 Nov; 179(5):1033-1048. PubMed ID: 29791718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-15 is a hair follicle immune privilege guardian.
    Suzuki T; Chéret J; Scala FD; Rajabi-Estarabadi A; Akhundlu A; Demetrius DL; Gherardini J; Keren A; Harries M; Rodriguez-Feliz J; Epstein G; Lee W; Purba T; Gilhar A; Paus R
    J Autoimmun; 2024 May; 145():103217. PubMed ID: 38581915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoactive intestinal peptide, whose receptor-mediated signalling may be defective in alopecia areata, provides protection from hair follicle immune privilege collapse.
    Bertolini M; Pretzlaff M; Sulk M; Bähr M; Gherardini J; Uchida Y; Reibelt M; Kinori M; Rossi A; Bíró T; Paus R
    Br J Dermatol; 2016 Sep; 175(3):531-41. PubMed ID: 27059672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hair follicle immune privilege and its collapse in alopecia areata.
    Bertolini M; McElwee K; Gilhar A; Bulfone-Paus S; Paus R
    Exp Dermatol; 2020 Aug; 29(8):703-725. PubMed ID: 32682334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage migration inhibitory factor polymorphism (rs755622) in alopecia areata: a possible role in disease prevention.
    Rajabi F; Amoli MM; Robati RM; Almasi-Nasrabadi M; Jabalameli N
    Arch Dermatol Res; 2019 Oct; 311(8):589-594. PubMed ID: 31154458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alopecia areata: a tissue specific autoimmune disease of the hair follicle.
    Gilhar A; Kalish RS
    Autoimmun Rev; 2006 Jan; 5(1):64-9. PubMed ID: 16338213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cross-sectional study of the histopathology and immunology of alopecia areata: Unearthing the role of the Janus kinase-signal transducer and activator of transcription pathway.
    Bansal A; Relhan V; Garg VK; Saran RK
    Indian J Dermatol Venereol Leprol; 2019; 85(5):455-461. PubMed ID: 31031313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of platelet-rich plasma on hair regrowth and lesional T-cell cytokine expression in alopecia areata: A randomized observer-blinded, placebo-controlled, split-head pilot study.
    Gupta V; Parihar AS; Sharma VK; Jain S; Singh V; Khanna N
    J Am Acad Dermatol; 2021 May; 84(5):1321-1328. PubMed ID: 33359595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mathematical model for alopecia areata.
    Dobreva A; Paus R; Cogan NG
    J Theor Biol; 2015 Sep; 380():332-45. PubMed ID: 26047853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pro-inflammatory Vδ1
    Uchida Y; Gherardini J; Schulte-Mecklenbeck A; Alam M; Chéret J; Rossi A; Kanekura T; Gross CC; Arakawa A; Gilhar A; Bertolini M; Paus R
    J Dermatol Sci; 2020 Nov; 100(2):129-138. PubMed ID: 33039243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack.
    Ito T; Ito N; Saatoff M; Hashizume H; Fukamizu H; Nickoloff BJ; Takigawa M; Paus R
    J Invest Dermatol; 2008 May; 128(5):1196-206. PubMed ID: 18160967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocytes, neuropeptides, and genes involved in alopecia areata.
    Gilhar A; Paus R; Kalish RS
    J Clin Invest; 2007 Aug; 117(8):2019-27. PubMed ID: 17671634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mediation of alopecia areata by cooperation between CD4+ and CD8+ T lymphocytes: transfer to human scalp explants on Prkdc(scid) mice.
    Gilhar A; Landau M; Assy B; Shalaginov R; Serafimovich S; Kalish RS
    Arch Dermatol; 2002 Jul; 138(7):916-22. PubMed ID: 12071819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exacerbation of alopecia areata during pegylated interferon alpha-2b and ribavirin therapy, possibly due to the collapse of hair follicle immune privilege.
    Ito T; Suzuki T; Funakoshi A; Tokura Y
    Eur J Dermatol; 2014; 24(5):631-3. PubMed ID: 25115439
    [No Abstract]   [Full Text] [Related]  

  • 19. Calcitonin gene-related peptide (CGRP) may award relative protection from interferon-γ-induced collapse of human hair follicle immune privilege.
    Kinori M; Bertolini M; Funk W; Samuelov L; Meyer KC; Emelianov VU; Hasse S; Paus R
    Exp Dermatol; 2012 Mar; 21(3):223-6. PubMed ID: 22379970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of neurogenic inflammation in the pathogenesis of alopecia areata.
    Shi Y; Wan S; Song X
    J Dermatol; 2024 May; 51(5):621-631. PubMed ID: 38605467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.